Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01206062 · ClinicalTrials.gov registry record · NA
Systolic Blood Pressure Intervention Trial
A NA study of Hypertension, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- Completed
- Registry status
- NA
- Development phase
- 9,361
- Enrollment target
- 1
- Study location
NCT01206062 is a NA study of Hypertension that has completed, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 9,361 participants, above the 3,487-participant average among 470 other Hypertension trials with a reported enrollment target (168% higher). The trial reports 1 study location across 1 state.
The verdict
NCT01206062, a NA study of Hypertension, has completed, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- COMPLETED
- Registry status
- NA
- Development phase
- 9,361 participants
- Enrollment target
- 1
- Study location
Study Summary
Elevated blood pressure (BP) is an important public health concern. It is highly prevalent, the prevalence may be increasing, and it is a risk factor for several adverse health outcomes, especially coronary heart disease, stroke, heart failure, chronic kidney disease, and decline in cognitive function. The Systolic Blood Pressure Intervention Trial (SPRINT) is a 2-arm, multicenter, randomized clinical trial designed to test whether a treatment program aimed at reducing systolic blood pressure (SBP) to a lower goal than currently recommended will reduce cardiovascular disease (CVD) risk.
Conditions Studied
Interventions
- DRUG Intensive control of SBP
- DRUG Standard control of SBP
Study Locations (1)
North Carolina
- Wake Forest University School of Medicine - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9,361 participants |
| Start Date | 2010-10 |
| Est. Completion | 2019-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01206062
The ClinicalTrials.gov registry entry for NCT01206062 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 9,361 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 3,487-participant average among 470 other Hypertension trials with a reported enrollment target (168% higher). The listed sponsor is National Heart, Lung, and Blood Institute (NHLBI), which has 501 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which Intensive control of SBP is the first listed.
NCT01206062 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT01206062 about?
NCT01206062 is a clinical study titled "Systolic Blood Pressure Intervention Trial". Elevated blood pressure (BP) is an important public health concern. It is highly prevalent, the prevalence may be increasing, and it is a risk factor for several adverse health outcomes, especially coronary heart disease, stroke, heart failure, chronic kidney disease, and decline in cognitive functi...
What is the current status of trial NCT01206062?
This trial is currently completed. It is a NA study. The enrollment target is 9,361 participants. The study started on 2010-10. Estimated completion is 2019-03.
What conditions does trial NCT01206062 study?
This clinical trial studies the following conditions: Hypertension.
What interventions are being tested in trial NCT01206062?
The interventions under investigation include: Intensive control of SBP (DRUG), Standard control of SBP (DRUG).
Who is sponsoring clinical trial NCT01206062?
This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01206062 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes
RECRUITING · NA
-
Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Early Time-Restricted Eating in Older Adults With Hypertension
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.